These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35970390)

  • 1. The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size.
    Zapata-Mercado E; Biener G; McKenzie DM; Wimley WC; Pasquale EB; Raicu V; Hristova K
    J Biol Chem; 2022 Oct; 298(10):102370. PubMed ID: 35970390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EphA2 receptor is activated through induction of distinct, ligand-dependent oligomeric structures.
    Singh DR; Kanvinde P; King C; Pasquale EB; Hristova K
    Commun Biol; 2018; 1():15. PubMed ID: 30271902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling.
    Gomez-Soler M; Petersen Gehring M; Lechtenberg BC; Zapata-Mercado E; Hristova K; Pasquale EB
    J Biol Chem; 2019 May; 294(22):8791-8805. PubMed ID: 31015204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor.
    Wykosky J; Palma E; Gibo DM; Ringler S; Turner CP; Debinski W
    Oncogene; 2008 Dec; 27(58):7260-73. PubMed ID: 18794797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
    Tandon M; Vemula SV; Sharma A; Ahi YS; Mittal S; Bangari DS; Mittal SK
    J Gene Med; 2012 Feb; 14(2):77-89. PubMed ID: 22228563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
    Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
    J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation.
    Yang XY; Zhu WJ; Jiang H
    Mol Cell Biochem; 2012 Feb; 361(1-2):259-65. PubMed ID: 22009484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase.
    Parri M; Buricchi F; Taddei ML; Giannoni E; Raugei G; Ramponi G; Chiarugi P
    J Biol Chem; 2005 Oct; 280(40):34008-18. PubMed ID: 16051609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells.
    Wykosky J; Gibo DM; Debinski W
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3208-18. PubMed ID: 18089715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
    Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells.
    Yang NY; Fernandez C; Richter M; Xiao Z; Valencia F; Tice DA; Pasquale EB
    Cell Signal; 2011 Jan; 23(1):201-12. PubMed ID: 20837138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatially modulated ephrinA1:EphA2 signaling increases local contractility and global focal adhesion dynamics to promote cell motility.
    Chen Z; Oh D; Biswas KH; Yu CH; Zaidel-Bar R; Groves JT
    Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5696-E5705. PubMed ID: 29866846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphA2 receptor activation by monomeric Ephrin-A1 on supported membranes.
    Xu Q; Lin WC; Petit RS; Groves JT
    Biophys J; 2011 Dec; 101(11):2731-9. PubMed ID: 22261062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of EphA2 by Dasatinib Suppresses Radiation-Induced Intestinal Injury.
    Kim A; Seong KM; Choi YY; Shim S; Park S; Lee SS
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33265912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.
    Wykosky J; Debinski W
    Mol Cancer Res; 2008 Dec; 6(12):1795-806. PubMed ID: 19074825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial organization of EphA2 at the cell-cell interface modulates trans-endocytosis of ephrinA1.
    Greene AC; Lord SJ; Tian A; Rhodes C; Kai H; Groves JT
    Biophys J; 2014 May; 106(10):2196-205. PubMed ID: 24853748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase A can block EphA2 receptor-mediated cell repulsion by increasing EphA2 S897 phosphorylation.
    Barquilla A; Lamberto I; Noberini R; Heynen-Genel S; Brill LM; Pasquale EB
    Mol Biol Cell; 2016 Sep; 27(17):2757-70. PubMed ID: 27385333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin-Producing Hepatoma Receptor Tyrosine Kinase A2 Modulation Associates with Protective Effect of Prone Position in Ventilator-induced Lung Injury.
    Park BH; Shin MH; Douglas IS; Chung KS; Song JH; Kim SY; Kim EY; Jung JY; Kang YA; Chang J; Kim YS; Park MS
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):519-529. PubMed ID: 29216437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pH-dependent membrane peptide that binds to EphA2 and inhibits cell migration.
    Alves DS; Westerfield JM; Shi X; Nguyen VP; Stefanski KM; Booth KR; Kim S; Morrell-Falvey J; Wang BC; Abel SM; Smith AW; Barrera FN
    Elife; 2018 Sep; 7():. PubMed ID: 30222105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand targeting of EphA2 enhances keratinocyte adhesion and differentiation via desmoglein 1.
    Lin S; Gordon K; Kaplan N; Getsios S
    Mol Biol Cell; 2010 Nov; 21(22):3902-14. PubMed ID: 20861311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.